CA Patent

CA2497059C — Blocking device for a locking-stressing-mechanism having a spring-actuated output drive device

Assigned to Boehringer Ingelheim International GmbH · Expires 2010-11-16 · 16y expired

What this patent protects

The service life of an apparatus is to be restricted if there are hygiene, medical or technical reasons for this. This requires a device which cannot be interfered with by the user of the apparatus, which will reliably, effectively and definitively prevent further use of the appa…

USPTO Abstract

The service life of an apparatus is to be restricted if there are hygiene, medical or technical reasons for this. This requires a device which cannot be interfered with by the user of the apparatus, which will reliably, effectively and definitively prevent further use of the apparatus once the prescribed number of actuations has been reached. A locking-stressing-mechanism with spring-actuated output drive and a counter with which an apparatus of this kind is fitted, accommodated in a two part housing the two parts of which are mounted to be rotatable relative to each other, can be blocked by means of a pre-stressed leaf spring. The leaf spring is initially accommodated in a recess in the wall of one housing part. As soon as the permitted number of actuations has been reached a push rod pushes the leaf spring out of its resting position. The leaf spring then jumps into a recess in the wall of the other housing part and the two housing parts can no longer be rotated relative to each other. The push rod may be mounted on the pointer of the counter. This blocking device can only be overcome by the application of a force which is sufficient to destroy the device. The device is suitable for blocking a high pressure atomiser or a needleless injector with which a fluid is atomised to form an aerosol or a fluid is injected into a biological tissue.

Drugs covered by this patent

Patent Metadata

Patent number
CA2497059C
Jurisdiction
CA
Classification
Expires
2010-11-16
Drug substance claim
No
Drug product claim
No
Assignee
Boehringer Ingelheim International GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.